Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Water Res ; 47(17): 6606-17, 2013 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-24064547

RESUMO

Legionella pneumophila is the agent responsible for legionellosis. Numerous bacteria, including L. pneumophila, can enter into a viable but not culturable (VBNC) state under unfavorable environmental conditions. In this state, cells are unable to form colonies on standard medium but are still alive. Here we show that VBNC L. pneumophila cells, obtained by monochloramine treatment, were still able to synthesize proteins, some of which are involved in virulence. Protein synthesis was measured using (35)S-labeling and the proteomes of VBNC and culturable cells then compared. This analysis allowed the identification of nine proteins that were accumulated in the VBNC state. Among them, four were involved in virulence, i.e., the macrophage infectivity potentiator protein, the hypothetical protein lpl2247, the ClpP protease proteolytic subunit and the 27 kDa outer membrane protein. Others, i.e., the enoyl reductase, the electron transfer flavoprotein (alpha and beta subunits), the 50S ribosomal proteins (L1 and L25) are involved in metabolic and energy production pathways. However, resuscitation experiments performed with Acanthamoeba castellanii failed, suggesting that the accumulation of virulence factors by VBNC cells is not sufficient to maintain their virulence.


Assuntos
Proteínas de Bactérias/biossíntese , Legionella pneumophila/citologia , Legionella pneumophila/patogenicidade , Viabilidade Microbiana , Fatores de Virulência/biossíntese , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Cloraminas/farmacologia , Esterases/metabolismo , Legionella pneumophila/efeitos dos fármacos , Legionella pneumophila/enzimologia , Viabilidade Microbiana/efeitos dos fármacos , Biossíntese de Proteínas/efeitos dos fármacos , Proteoma/metabolismo
2.
Biochim Biophys Acta ; 1808(4): 1146-53, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21182824

RESUMO

Warnericin RK is an antimicrobial peptide, produced by a Staphyloccocus warneri strain, described to be specifically active against Legionella, the pathogenic bacteria responsible for Legionnaires' disease. Warnericin RK is an amphiphilic alpha-helical peptide, which possesses a detergent-like mode of action. Two others peptides, δ-hemolysin I and II, produced by the same S. warneri strain, are highly similar to S. aureus δ-hemolysin and also display anti-Legionella activity. It has been recently reported that S. aureus δ-hemolysin activity on vesicles is likewise related to phospholipid acyl-chain structure, such as chain length and saturation. As staphylococcal δ-hemolysins were highly similar, we thus hypothesized that fatty acid composition of Legionella's membrane might influence the sensitivity of the bacteria to warnericin RK. Relationship between sensitivity to the peptide and fatty acid composition was then followed in various conditions. Cells in stationary phase, which were already described as less resistant than cells in exponential phase, displayed higher amounts of branched-chain fatty acids (BCFA) and short chain fatty acids. An adapted strain, able to grow at a concentration 33 fold higher than minimal inhibitory concentration of the wild type (i.e. 1µM), was isolated after repeated transfers of L. pneumophila in the presence of increased concentrations of warnericin RK. The amount of BCFA was significantly higher in the adapted strain than in the wild type strain. Also, a transcriptomic analysis of the wild type and adapted strains showed that two genes involved in fatty acid biosynthesis were repressed in the adapted strain. These genes encode enzymes involved in desaturation and elongation of fatty acids respectively. Their repression was in agreement with the decrease of unsaturated fatty acids and fatty acid chain length in the adapted strain. Conclusively, our results indicate that the increase of BCFA and the decrease of fatty acid chain length in membrane were correlated with the increase in resistance to warnericin RK. Therefore, fatty acid profile seems to play a critical role in the sensitivity of L. pneumophila to warnericin RK.


Assuntos
Antibacterianos/farmacologia , Bacteriocinas/farmacologia , Membrana Celular/efeitos dos fármacos , Ácidos Graxos/análise , Legionella pneumophila/efeitos dos fármacos , Proteínas de Bactérias/farmacologia , Membrana Celular/química , Permeabilidade da Membrana Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Farmacorresistência Bacteriana , Perfilação da Expressão Gênica , Regulação Bacteriana da Expressão Gênica , Legionella pneumophila/genética , Lipídeos de Membrana/química , Testes de Sensibilidade Microbiana , Análise de Sequência com Séries de Oligonucleotídeos , Staphylococcus/metabolismo
3.
Peptides ; 30(4): 817-23, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19150639

RESUMO

delta-hemolysin is a hemolytic peptide produced by Staphylococcus, and it has been studied for nearly 50 years. Therefore, it has become a model in the study of peptides interacting with membranes. In this review, we report some recent findings and compare them with previous works. delta-hemolysin is a 26 amino acid peptide, somewhat hydrophobic and presenting a zero net charge. Study of its structure has shown that delta-hemolysin is alpha-helical and amphipathic, such as many antimicrobial peptides (e.g. magainin and melittin). However, delta-hemolysin had not displayed any reported antimicrobial activity until a recent publication showed its high potency against Legionella. Its mode of action is based on direct interaction with target membranes. In accordance with its concentration, delta-hemolysin may slightly perturb a membrane or lead to cell lysis. Peptide charge plays an important role in its interaction with membranes, as is shown in the study of peptide variants. Some positively charged variants become highly hemolytic and even active against Escherichia coli and Staphylococcus aureus. Finally, it has recently been demonstrated that peptide preferentially binds to lipid-disordered domains. It has been postulated that as a result, enrichment in lipid-ordered domains might increase peptide concentration in lipid-disordered domains and thereby improve its activity.


Assuntos
Proteínas de Bactérias/farmacologia , Proteínas Hemolisinas/farmacologia , Sequência de Aminoácidos , Animais , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Membrana Celular/efeitos dos fármacos , Proteínas Hemolisinas/química , Proteínas Hemolisinas/genética , Humanos , Dados de Sequência Molecular , Conformação Proteica , Relação Estrutura-Atividade
4.
Curr Microbiol ; 57(5): 497-502, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18839249

RESUMO

Legionella pneumophila, a facultative intracellular human pathogen, can persist for long periods in natural and artificial aquatic environments. Eradication of this bacterium from plumbing systems is often difficult. We tested L. pneumophila survival after monochloramine treatment. Survival was monitored using the BacLight Bacterial Viability Kit (Molecular Probes), ChemChrome V6 Kit (Chemunex), quantitative polymerase chain reaction and culturability on buffered charcoal-yeast extract agar. In nonculturable samples, regain of culturability was obtained after addition of the amoeba Acanthamoeba castellanii, and esterase activity and membrane integrity were observed after >4 months after treatment. These results demonstrate for the first time that L. pneumophila could persist for long periods in biofilms into the viable but nonculturable (VBNC) state. Monitoring L. pneumophila in water networks is generally done by enumeration on standard solid medium. This method does not take into account VBNC bacteria. VBNC L. pneumophila could persist for long periods and should be resuscitated by amoeba. These cells constitute potential sources of contamination and should be taken into account in monitoring water networks.


Assuntos
Cloraminas/farmacologia , Legionella pneumophila/efeitos dos fármacos , Legionella pneumophila/crescimento & desenvolvimento , Viabilidade Microbiana/efeitos dos fármacos , Microbiologia da Água , Acanthamoeba castellanii/microbiologia , Animais , Desinfetantes/farmacologia , Legionella pneumophila/genética , Reação em Cadeia da Polimerase
5.
Peptides ; 29(6): 978-84, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18339450

RESUMO

Legionella pneumophila, the causative agent of Legionnaires' disease, is a waterborne bacteria. It can multiply in man-made water systems and infect people who inhale contaminated droplets. We have previously reported a Staphylococcus warneri strain that display an anti-Legionella activity. In this work, we characterized three anti-Legionella peptides that are produced by S. warneri. One peptide, warnericin RK, is original, while the two others are delta-lysin I and delta-lysin II, whose genes were previously described. Due to high sequence similarity of the two delta-lysins, further characterization was performed only on delta-lysin I. Warnericin RK and delta-lysin I displayed the same antibacterial spectrum, which is almost restricted to the Legionella genus. Also, both peptides have a hemolytic activity. These results led to the hypothesis that warnericin RK and delta-lysin I share a similar mode of action, and that Legionella should have a specific feature that may explain the high specificity of these antibacterial peptides.


Assuntos
Proteínas de Bactérias/farmacologia , Proteínas Hemolisinas/farmacologia , Legionella pneumophila/efeitos dos fármacos , Peptídeos/farmacologia , Staphylococcus/metabolismo , Sequência de Aminoácidos , Antibacterianos/farmacologia , Proteínas de Bactérias/química , Relação Dose-Resposta a Droga , Eritrócitos/efeitos dos fármacos , Proteínas Hemolisinas/química , Hemólise/efeitos dos fármacos , Hemólise/fisiologia , Humanos , Interações Hidrofóbicas e Hidrofílicas , Legionella pneumophila/crescimento & desenvolvimento , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Peptídeos/química , Peptídeos/isolamento & purificação , Estrutura Secundária de Proteína , Homologia de Sequência de Aminoácidos , Staphylococcus/química , Staphylococcus/crescimento & desenvolvimento , Staphylococcus/isolamento & purificação
6.
J Bacteriol ; 187(6): 2218-23, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15743973

RESUMO

By site-specific mutagenesis, the hydrophobic conserved amino acids and the C-terminal GG doublet of the leader peptide of pre-mesentericin Y105 were demonstrated to be critical for optimal secretion of mesentericin Y105, as well as for the maturation of the pre-bacteriocin by the protease portion of the ABC transporter MesD.


Assuntos
Bacteriocinas/genética , Bacteriocinas/metabolismo , Leuconostoc/genética , Leuconostoc/metabolismo , Sequência de Aminoácidos , Substituição de Aminoácidos , Bacteriocinas/química , Citoplasma/metabolismo , Interações Hidrofóbicas e Hidrofílicas , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Estrutura Terciária de Proteína
7.
Appl Environ Microbiol ; 70(8): 4672-80, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15294801

RESUMO

Mesentericin Y105 is a 37-residue bacteriocin produced by Leuconostoc mesenteroides Y105 that displays antagonistic activity against gram-positive bacteria such as Enterococcus faecalis and Listeria monocytogenes. It is closely related to leucocin A, an antimicrobial peptide containing beta-sheet and alpha-helical structures. To analyze structure-function relationships and the mode of action of this bacteriocin, we generated a collection of mesentericin derivatives. Mutations were obtained mostly by PCR random mutagenesis, and the peptides were produced by an original system of heterologous expression recently described. Ten derivatives were obtained displaying modifications at eight different positions in the mesentericin Y105 sequence. Purified peptides were incorporated into lysophosphatidylcholine micelles and analyzed by circular dichroism. The alpha-helical contents of these peptides were compared and related to their respective bactericidal activities. Moreover, studies of the intrinsic fluorescence of tryptophan residues naturally occurring at positions 18 and 37 revealed information about insertion of the peptides in micelles. A model for the mode of action of mesentericin Y105 and related bacteriocins is proposed.


Assuntos
Bacteriocinas , Listeria/efeitos dos fármacos , Mutação , Sequência de Aminoácidos , Bacteriocinas/química , Bacteriocinas/genética , Bacteriocinas/metabolismo , Bacteriocinas/farmacologia , Membrana Celular/metabolismo , Dicroísmo Circular , Leuconostoc/metabolismo , Listeria monocytogenes/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Alinhamento de Sequência , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...